Launching the Intro to Oncology Page

BOPA is thrilled to launch a new dedicated page on our website for the Introduction to Oncology course. The page can be accessed under the education tab, or the address link below. 

https://www.bopa.org.uk/intro_to_onc_2023/ 

The Introduction to Oncology study day has been a mainstay of BOPA’s continued effort to promote excellence in the pharmaceutical care of patients with cancer through education by supporting pharmacy practitioners venturing into the oncology specialty with fundamental knowledges. 

The oncology pharmacy workforces have developed and expanded significantly over the past decade, and the Introduction to Oncology course has also evolved to keep its content relevant and up-to-date to current practices. This year the Intro to Oncology course has a major update. The course has been redeveloped into a 2-day format, incorporating more educational material suitable for different entry-level oncology pharmacy practitioners. 

The course is also being held in two different cities to accommodate members travelling from different locations and to cater the popular demand. 

The new Intro to Oncology page will showcase the successes of the course, and become the central hub for all members to access news and information about the course. 

Kudos to the Education and Training Subcommittee for the hard work in hosting the Introduction to Oncology course!

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article